Stockscreener 앱 받기
8.01
2.96%
0.23
전일 마감가:
$7.78
열려 있는:
$7.77
하루 거래량:
5.41M
Relative Volume:
1.35
시가총액:
$1.30B
수익:
$1.08B
순이익/손실:
$422.82M
주가수익비율:
3.5132
EPS:
2.28
순현금흐름:
$-637.33M
1주 성능:
+10.18%
1개월 성능:
+22.48%
6개월 성능:
+15.09%
1년 성능:
-6.10%
1일 변동 폭
$7.73
$8.33
1주일 범위
$7.15
$8.81
52주 변동 폭
$5.01
$10.64
노바백스 Stock (NVAX) Company Profile
명칭
Novavax Inc
전화
240-268-2000
주소
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
NVAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
8.01 | 1.26B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
노바백스 Stock (NVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-08-28 | 재개 | H.C. Wainwright | Buy |
| 2025-08-20 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2025-06-17 | 개시 | Citigroup | Sell |
| 2025-02-28 | 개시 | BTIG Research | Buy |
| 2024-07-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-05-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-05-10 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-08-09 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | 재확인 | B. Riley Securities | Buy |
| 2022-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2022-12-02 | 개시 | Jefferies | Hold |
| 2022-09-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2022-02-22 | 재개 | Jefferies | Buy |
| 2022-01-21 | 개시 | Cowen | Outperform |
| 2021-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-12-14 | 개시 | Jefferies | Buy |
| 2020-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-08-05 | 다운그레이드 | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | 재확인 | B. Riley FBR | Buy |
| 2020-06-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-05-28 | 재확인 | B. Riley FBR | Buy |
| 2020-05-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-30 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-08-14 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-12-11 | 개시 | Oppenheimer | Outperform |
| 2018-11-26 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2018-03-29 | 업그레이드 | Seaport Global Securities | Neutral → Buy |
모두보기
노바백스 주식(NVAX)의 최신 뉴스
Aug Breakouts: Will Novavax Inc face regulatory challenges2025 Performance Recap & Low Risk High Win Rate Picks - baoquankhu1.vn
Understanding the Setup: (NVAX) and Scalable Risk - Stock Traders Daily
Bank of America Securities Reaffirms Their Sell Rating on Novavax (NVAX) - The Globe and Mail
JPM26: Matrix-M Technology is central to Novavax’s strategy - Pharmaceutical Technology
Novavax Shares Slide as Long-Term Analysis Flags High Risk - cedarkeybeacon.com
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy - PharmExec.com
Novavax (NVAX) Is Up 7.5% After Pivot To Partner-Led Model And Sanofi CollaborationHas The Bull Case Changed? - Yahoo Finance
Improved Revenues Required Before Novavax, Inc. (NASDAQ:NVAX) Stock's 32% Jump Looks Justified - Sahm
NVAX: Lean, partner-focused strategy drives growth, with profitability targeted by 2028 - TradingView — Track All Markets
J.P. Morgan Notebook: Novavax On US FDA Requests, Takeda’s Strategies For FDA Change - Citeline News & Insights
Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance
Novavax (NASDAQ:NVAX) Trading Down 6.1%What's Next? - MarketBeat
Aug Opening: Can Novavax Inc stock outperform in a bear market2025 Bull vs Bear & Verified Short-Term Trading Plans - baoquankhu1.vn
Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last? - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Institutional Owners May Be Pleased With Recent Gains After 8.9% Loss Over the Past Year - 富途牛牛
CORRECTED: Why Is Novavax Stock Soaring? - Benzinga
Novavax (NASDAQ:NVAX) Trading 5.5% HigherHere's What Happened - MarketBeat
Novavax’s Recent Market Movements: A Deep Dive - StocksToTrade
HHS secretary RFK Jr. adds two new members to CDC vaccine panel - Seeking Alpha
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - sharewise.com
Novavax (NVAX) Stock: Why Investors Bought the Turnaround Story - Blockonomi
Novavax stock outlook positive as Cantor Fitzgerald sees growth in 2026 - Investing.com Australia
Novavax stock outlook positive as Cantor Fitzgerald sees growth in 2026 By Investing.com - Investing.com India
Novavax (NVAX) Stock: New Partnership Strategy Drives 8% Rally on Monday - CoinCentral
Novavax, Inc. (NVAX) Stock Analysis: Exploring a 64.87% Potential Upside Amid Volatile Biotech Landscape - DirectorsTalk Interviews
Smart Money: Is Novavax Inc stock technically oversoldTake Profit & Community Verified Trade Alerts - baoquankhu1.vn
Novavax’s Strategic Pivot: A 2026 Transformation in Focus - AD HOC NEWS
Why Novavax Inc. stock is favored by pension fundsJuly 2025 Highlights & Safe Entry Point Identification - ulpravda.ru
How strong is Novavax Inc. stock balance sheetJuly 2025 Sector Moves & AI Driven Price Forecasts - ulpravda.ru
Why Novavax Inc. stock remains a top recommendationEarnings Overview Summary & Verified Short-Term Plans - ulpravda.ru
Will Novavax Inc. stock gain from strong economyBuy Signal & Weekly High Conviction Trade Ideas - ulpravda.ru
How Novavax Inc. stock performs in high volatility markets2025 Bull vs Bear & Verified Short-Term Trading Plans - ulpravda.ru
Is Novavax Inc. (NVV1) stock a safe buy pre earningsQuarterly Profit Review & AI Driven Price Forecasts - ulpravda.ru
Merger Talk: Is Novavax Inc. stock overvalued by current metricsQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - ulpravda.ru
Is Novavax Inc. stock overvalued by current metricsRisk Management & Low Drawdown Momentum Ideas - ulpravda.ru
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
San Gabriel Valley Tribune - FinancialContent
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GuruFocus
Is Novavax (NVAX) Mispriced After Recent Share Rebound And DCF Upside Projection - Yahoo Finance
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX) - MarketBeat
Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Mixed Analyst Targets - Yahoo Finance
The Technical Signals Behind (NVAX) That Institutions Follow - Stock Traders Daily
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
CDC overhauls childhood vaccine schedule (PFE:NYSE) - Seeking Alpha
Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks - Finviz
Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Novavax stock today: NVAX closes up 6% as Singapore rolls out JN.1 Novavax COVID shot - ts2.tech
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Novavax (NVAX) Stock Trades Up, Here Is Why - The Globe and Mail
Novavax (NVAX) Stock Up 3% as JN.1 COVID-19 Vaccine Launches in Singapore ClinicsNews and Statistics - IndexBox
Risk Hedge: Is Novavax Inc NVV1 stock undervalued after correctionEarnings Beat & Real-Time Buy Signal Alerts - moha.gov.vn
노바백스 (NVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
노바백스 주식 (NVAX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Draghia-Akli Ruxandra | Section 16 |
Nov 11 '25 |
Option Exercise |
0.00 |
14,257 |
0 |
14,257 |
| MCGLYNN MARGARET G | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,588 |
| Alton Gregg H | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
28,805 |
| King Rachel K. | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,190 |
| Rodgers Richard J | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
24,690 |
| MOTT DAVID M | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
60,890 |
| DOUGLAS RICHARD | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
54,340 |
4.73%
0.92%
자본화:
|
볼륨(24시간):